S&P DJI Announces March 2023 Quarterly Rebalance
Filed with ASX · · 8 pages · English
Story so far
Earlier from ImpediMed
- Appendix 4C & Quarterly Activities Report - Dec-22 Qtr
- New Version of NCCN Guidelines for Breast Cancer
- ImpediMed Announces Appointment of Managing Director and CEO
- ImpediMed Announces Management Reorganisation
- AstraZeneca Further Extends Clinical Trial Contract
Later from ImpediMed
- NCCN Guidelines Now Recommend Bioimpedance Spectroscopy
- Appendix 4C & Quarterly Activities Report - Mar-23 Qtr
- SOZO Pro Achieves Clearance by U.S. FDA
- Trading Halt
- Placement and SPP Notification
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed